nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—Parkinson's disease—Diphenhydramine—allergic rhinitis	0.472	1	CpDpCtD
Pramipexole—HTR2B—Cyproheptadine—allergic rhinitis	0.0763	0.222	CbGbCtD
Pramipexole—HTR2C—Cyproheptadine—allergic rhinitis	0.0496	0.145	CbGbCtD
Pramipexole—HTR1A—Cyproheptadine—allergic rhinitis	0.0468	0.136	CbGbCtD
Pramipexole—SLC22A2—Diphenhydramine—allergic rhinitis	0.045	0.131	CbGbCtD
Pramipexole—HTR2A—Cyproheptadine—allergic rhinitis	0.0448	0.131	CbGbCtD
Pramipexole—DRD2—Cyproheptadine—allergic rhinitis	0.0412	0.12	CbGbCtD
Pramipexole—SLC22A1—Diphenhydramine—allergic rhinitis	0.0391	0.114	CbGbCtD
Pramipexole—DRD3—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.44e-05	0.00232	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—TAC1—allergic rhinitis	4.39e-05	0.0023	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.35e-05	0.00228	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—PTGDR2—allergic rhinitis	4.33e-05	0.00227	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—TAC1—allergic rhinitis	4.33e-05	0.00226	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.28e-05	0.00224	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	4.22e-05	0.00221	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—PTGDR2—allergic rhinitis	4.09e-05	0.00214	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—CCL11—allergic rhinitis	4.08e-05	0.00213	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.07e-05	0.00213	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—PTGDR2—allergic rhinitis	4.03e-05	0.00211	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.01e-05	0.0021	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.99e-05	0.00209	CbGpPWpGaD
Pramipexole—Bradycardia—Dexamethasone—allergic rhinitis	3.98e-05	0.00024	CcSEcCtD
Pramipexole—DRD4—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.92e-05	0.00205	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—TAC1—allergic rhinitis	3.91e-05	0.00204	CbGpPWpGaD
Pramipexole—Angiopathy—Methylprednisolone—allergic rhinitis	3.9e-05	0.000235	CcSEcCtD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	3.89e-05	0.00204	CbGpPWpGaD
Pramipexole—Hallucination—Dexamethasone—allergic rhinitis	3.89e-05	0.000235	CcSEcCtD
Pramipexole—Hallucination—Betamethasone—allergic rhinitis	3.89e-05	0.000235	CcSEcCtD
Pramipexole—Immune system disorder—Methylprednisolone—allergic rhinitis	3.88e-05	0.000234	CcSEcCtD
Pramipexole—Mediastinal disorder—Methylprednisolone—allergic rhinitis	3.87e-05	0.000234	CcSEcCtD
Pramipexole—HTR1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.87e-05	0.00203	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.85e-05	0.00202	CbGpPWpGaD
Pramipexole—Vision blurred—Prednisolone—allergic rhinitis	3.84e-05	0.000232	CcSEcCtD
Pramipexole—Vomiting—Montelukast—allergic rhinitis	3.83e-05	0.000231	CcSEcCtD
Pramipexole—Rash—Montelukast—allergic rhinitis	3.79e-05	0.000229	CcSEcCtD
Pramipexole—Dermatitis—Montelukast—allergic rhinitis	3.79e-05	0.000229	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisolone—allergic rhinitis	3.78e-05	0.000228	CcSEcCtD
Pramipexole—HTR1A—GPCR ligand binding—TAC1—allergic rhinitis	3.77e-05	0.00197	CbGpPWpGaD
Pramipexole—Headache—Montelukast—allergic rhinitis	3.77e-05	0.000227	CcSEcCtD
Pramipexole—Visual impairment—Dexamethasone—allergic rhinitis	3.77e-05	0.000227	CcSEcCtD
Pramipexole—Visual impairment—Betamethasone—allergic rhinitis	3.77e-05	0.000227	CcSEcCtD
Pramipexole—Mental disorder—Methylprednisolone—allergic rhinitis	3.77e-05	0.000227	CcSEcCtD
Pramipexole—HTR2C—GPCR ligand binding—TAC1—allergic rhinitis	3.75e-05	0.00196	CbGpPWpGaD
Pramipexole—Erythema—Triamcinolone—allergic rhinitis	3.75e-05	0.000226	CcSEcCtD
Pramipexole—HTR2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.75e-05	0.00196	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.75e-05	0.00196	CbGpPWpGaD
Pramipexole—Malnutrition—Methylprednisolone—allergic rhinitis	3.74e-05	0.000226	CcSEcCtD
Pramipexole—Erythema—Methylprednisolone—allergic rhinitis	3.74e-05	0.000226	CcSEcCtD
Pramipexole—DRD5—GPCR downstream signaling—TAC1—allergic rhinitis	3.73e-05	0.00195	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.7e-05	0.00194	CbGpPWpGaD
Pramipexole—Ill-defined disorder—Hydrocortisone—allergic rhinitis	3.69e-05	0.000223	CcSEcCtD
Pramipexole—Malaise—Prednisolone—allergic rhinitis	3.68e-05	0.000222	CcSEcCtD
Pramipexole—Dysgeusia—Triamcinolone—allergic rhinitis	3.67e-05	0.000222	CcSEcCtD
Pramipexole—Vertigo—Prednisolone—allergic rhinitis	3.66e-05	0.000221	CcSEcCtD
Pramipexole—Syncope—Prednisolone—allergic rhinitis	3.66e-05	0.000221	CcSEcCtD
Pramipexole—Eye disorder—Betamethasone—allergic rhinitis	3.65e-05	0.00022	CcSEcCtD
Pramipexole—Eye disorder—Dexamethasone—allergic rhinitis	3.65e-05	0.00022	CcSEcCtD
Pramipexole—ADRA2C—GPCR ligand binding—TAC1—allergic rhinitis	3.65e-05	0.00191	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—PTGDR2—allergic rhinitis	3.64e-05	0.00191	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—PTGDR2—allergic rhinitis	3.63e-05	0.0019	CbGpPWpGaD
Pramipexole—Back pain—Triamcinolone—allergic rhinitis	3.63e-05	0.000219	CcSEcCtD
Pramipexole—HTR1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.62e-05	0.00189	CbGpPWpGaD
Pramipexole—Malaise—Hydrocortisone—allergic rhinitis	3.59e-05	0.000217	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisolone—allergic rhinitis	3.58e-05	0.000216	CcSEcCtD
Pramipexole—Vertigo—Hydrocortisone—allergic rhinitis	3.58e-05	0.000216	CcSEcCtD
Pramipexole—Nausea—Montelukast—allergic rhinitis	3.57e-05	0.000216	CcSEcCtD
Pramipexole—HTR1D—Signaling by GPCR—CCL11—allergic rhinitis	3.57e-05	0.00187	CbGpPWpGaD
Pramipexole—Syncope—Hydrocortisone—allergic rhinitis	3.57e-05	0.000215	CcSEcCtD
Pramipexole—DRD4—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.56e-05	0.00186	CbGpPWpGaD
Pramipexole—Angiopathy—Betamethasone—allergic rhinitis	3.55e-05	0.000214	CcSEcCtD
Pramipexole—Angiopathy—Dexamethasone—allergic rhinitis	3.55e-05	0.000214	CcSEcCtD
Pramipexole—Convulsion—Prednisolone—allergic rhinitis	3.53e-05	0.000213	CcSEcCtD
Pramipexole—DRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.53e-05	0.00185	CbGpPWpGaD
Pramipexole—Hypertension—Prednisolone—allergic rhinitis	3.52e-05	0.000212	CcSEcCtD
Pramipexole—HTR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	3.51e-05	0.00184	CbGpPWpGaD
Pramipexole—Loss of consciousness—Hydrocortisone—allergic rhinitis	3.5e-05	0.000211	CcSEcCtD
Pramipexole—HTR2C—Signaling by GPCR—PTGDR2—allergic rhinitis	3.5e-05	0.00183	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—CCL11—allergic rhinitis	3.5e-05	0.00183	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.48e-05	0.00182	CbGpPWpGaD
Pramipexole—Ill-defined disorder—Triamcinolone—allergic rhinitis	3.48e-05	0.00021	CcSEcCtD
Pramipexole—Ill-defined disorder—Methylprednisolone—allergic rhinitis	3.47e-05	0.000209	CcSEcCtD
Pramipexole—DRD5—GPCR downstream signaling—IL5—allergic rhinitis	3.47e-05	0.00181	CbGpPWpGaD
Pramipexole—Alopecia—Betamethasone—allergic rhinitis	3.45e-05	0.000208	CcSEcCtD
Pramipexole—Alopecia—Dexamethasone—allergic rhinitis	3.45e-05	0.000208	CcSEcCtD
Pramipexole—Convulsion—Hydrocortisone—allergic rhinitis	3.45e-05	0.000208	CcSEcCtD
Pramipexole—DRD4—Signaling by GPCR—CCL11—allergic rhinitis	3.44e-05	0.0018	CbGpPWpGaD
Pramipexole—Hypertension—Hydrocortisone—allergic rhinitis	3.44e-05	0.000207	CcSEcCtD
Pramipexole—Discomfort—Prednisolone—allergic rhinitis	3.43e-05	0.000207	CcSEcCtD
Pramipexole—Erythema—Dexamethasone—allergic rhinitis	3.4e-05	0.000205	CcSEcCtD
Pramipexole—Erythema—Betamethasone—allergic rhinitis	3.4e-05	0.000205	CcSEcCtD
Pramipexole—ADRA2C—Signaling by GPCR—PTGDR2—allergic rhinitis	3.4e-05	0.00178	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.4e-05	0.00178	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.4e-05	0.00178	CbGpPWpGaD
Pramipexole—Myalgia—Hydrocortisone—allergic rhinitis	3.39e-05	0.000205	CcSEcCtD
Pramipexole—DRD5—Signaling by GPCR—TAC1—allergic rhinitis	3.39e-05	0.00177	CbGpPWpGaD
Pramipexole—Malaise—Triamcinolone—allergic rhinitis	3.38e-05	0.000204	CcSEcCtD
Pramipexole—Anxiety—Hydrocortisone—allergic rhinitis	3.38e-05	0.000204	CcSEcCtD
Pramipexole—Malaise—Methylprednisolone—allergic rhinitis	3.37e-05	0.000204	CcSEcCtD
Pramipexole—Vertigo—Triamcinolone—allergic rhinitis	3.37e-05	0.000203	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	3.37e-05	0.000203	CcSEcCtD
Pramipexole—Syncope—Triamcinolone—allergic rhinitis	3.36e-05	0.000203	CcSEcCtD
Pramipexole—Vertigo—Methylprednisolone—allergic rhinitis	3.36e-05	0.000203	CcSEcCtD
Pramipexole—Syncope—Methylprednisolone—allergic rhinitis	3.35e-05	0.000202	CcSEcCtD
Pramipexole—Discomfort—Hydrocortisone—allergic rhinitis	3.35e-05	0.000202	CcSEcCtD
Pramipexole—HTR2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.34e-05	0.00175	CbGpPWpGaD
Pramipexole—Oedema—Prednisolone—allergic rhinitis	3.33e-05	0.000201	CcSEcCtD
Pramipexole—DRD2—GPCR ligand binding—TAC1—allergic rhinitis	3.31e-05	0.00173	CbGpPWpGaD
Pramipexole—Loss of consciousness—Triamcinolone—allergic rhinitis	3.3e-05	0.000199	CcSEcCtD
Pramipexole—Loss of consciousness—Methylprednisolone—allergic rhinitis	3.29e-05	0.000198	CcSEcCtD
Pramipexole—HTR2B—Signaling by GPCR—CCL11—allergic rhinitis	3.28e-05	0.00172	CbGpPWpGaD
Pramipexole—Shock—Prednisolone—allergic rhinitis	3.27e-05	0.000198	CcSEcCtD
Pramipexole—Cough—Triamcinolone—allergic rhinitis	3.27e-05	0.000197	CcSEcCtD
Pramipexole—HTR2A—GPCR ligand binding—TAC1—allergic rhinitis	3.26e-05	0.00171	CbGpPWpGaD
Pramipexole—Oedema—Hydrocortisone—allergic rhinitis	3.25e-05	0.000196	CcSEcCtD
Pramipexole—Convulsion—Triamcinolone—allergic rhinitis	3.25e-05	0.000196	CcSEcCtD
Pramipexole—ADRA2B—Hemostasis—IL5—allergic rhinitis	3.25e-05	0.0017	CbGpPWpGaD
Pramipexole—Tachycardia—Prednisolone—allergic rhinitis	3.25e-05	0.000196	CcSEcCtD
Pramipexole—Convulsion—Methylprednisolone—allergic rhinitis	3.24e-05	0.000196	CcSEcCtD
Pramipexole—Hypertension—Triamcinolone—allergic rhinitis	3.24e-05	0.000195	CcSEcCtD
Pramipexole—Hypertension—Methylprednisolone—allergic rhinitis	3.23e-05	0.000195	CcSEcCtD
Pramipexole—Infection—Hydrocortisone—allergic rhinitis	3.23e-05	0.000195	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisolone—allergic rhinitis	3.22e-05	0.000194	CcSEcCtD
Pramipexole—DRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.21e-05	0.00168	CbGpPWpGaD
Pramipexole—Shock—Hydrocortisone—allergic rhinitis	3.2e-05	0.000193	CcSEcCtD
Pramipexole—Myalgia—Triamcinolone—allergic rhinitis	3.19e-05	0.000193	CcSEcCtD
Pramipexole—Nervous system disorder—Hydrocortisone—allergic rhinitis	3.19e-05	0.000192	CcSEcCtD
Pramipexole—Myalgia—Methylprednisolone—allergic rhinitis	3.19e-05	0.000192	CcSEcCtD
Pramipexole—Arthralgia—Methylprednisolone—allergic rhinitis	3.19e-05	0.000192	CcSEcCtD
Pramipexole—Anxiety—Methylprednisolone—allergic rhinitis	3.17e-05	0.000192	CcSEcCtD
Pramipexole—Tachycardia—Hydrocortisone—allergic rhinitis	3.17e-05	0.000191	CcSEcCtD
Pramipexole—DRD3—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.16e-05	0.00166	CbGpPWpGaD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	3.16e-05	0.000191	CcSEcCtD
Pramipexole—Skin disorder—Hydrocortisone—allergic rhinitis	3.16e-05	0.00019	CcSEcCtD
Pramipexole—Ill-defined disorder—Betamethasone—allergic rhinitis	3.16e-05	0.00019	CcSEcCtD
Pramipexole—Ill-defined disorder—Dexamethasone—allergic rhinitis	3.16e-05	0.00019	CcSEcCtD
Pramipexole—Discomfort—Triamcinolone—allergic rhinitis	3.15e-05	0.00019	CcSEcCtD
Pramipexole—DRD5—Signaling by GPCR—IL5—allergic rhinitis	3.15e-05	0.00165	CbGpPWpGaD
Pramipexole—Discomfort—Methylprednisolone—allergic rhinitis	3.15e-05	0.00019	CcSEcCtD
Pramipexole—ADRA2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.15e-05	0.00165	CbGpPWpGaD
Pramipexole—Hyperhidrosis—Hydrocortisone—allergic rhinitis	3.14e-05	0.00019	CcSEcCtD
Pramipexole—Dry mouth—Triamcinolone—allergic rhinitis	3.12e-05	0.000188	CcSEcCtD
Pramipexole—Anorexia—Hydrocortisone—allergic rhinitis	3.1e-05	0.000187	CcSEcCtD
Pramipexole—DRD1—Signaling by GPCR—CCL11—allergic rhinitis	3.1e-05	0.00162	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—PTGDR2—allergic rhinitis	3.09e-05	0.00161	CbGpPWpGaD
Pramipexole—Confusional state—Methylprednisolone—allergic rhinitis	3.08e-05	0.000186	CcSEcCtD
Pramipexole—Malaise—Betamethasone—allergic rhinitis	3.07e-05	0.000185	CcSEcCtD
Pramipexole—Malaise—Dexamethasone—allergic rhinitis	3.07e-05	0.000185	CcSEcCtD
Pramipexole—Oedema—Triamcinolone—allergic rhinitis	3.06e-05	0.000185	CcSEcCtD
Pramipexole—Vertigo—Dexamethasone—allergic rhinitis	3.06e-05	0.000184	CcSEcCtD
Pramipexole—Vertigo—Betamethasone—allergic rhinitis	3.06e-05	0.000184	CcSEcCtD
Pramipexole—DRD3—Signaling by GPCR—CCL11—allergic rhinitis	3.06e-05	0.0016	CbGpPWpGaD
Pramipexole—Syncope—Betamethasone—allergic rhinitis	3.05e-05	0.000184	CcSEcCtD
Pramipexole—Syncope—Dexamethasone—allergic rhinitis	3.05e-05	0.000184	CcSEcCtD
Pramipexole—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.04e-05	0.00159	CbGpPWpGaD
Pramipexole—Infection—Triamcinolone—allergic rhinitis	3.04e-05	0.000183	CcSEcCtD
Pramipexole—HTR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.04e-05	0.00159	CbGpPWpGaD
Pramipexole—Hypotension—Hydrocortisone—allergic rhinitis	3.04e-05	0.000183	CcSEcCtD
Pramipexole—HTR2A—Signaling by GPCR—PTGDR2—allergic rhinitis	3.04e-05	0.00159	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—IL5—allergic rhinitis	3.03e-05	0.00159	CbGpPWpGaD
Pramipexole—Infection—Methylprednisolone—allergic rhinitis	3.03e-05	0.000183	CcSEcCtD
Pramipexole—HTR2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.02e-05	0.00158	CbGpPWpGaD
Pramipexole—Shock—Triamcinolone—allergic rhinitis	3.01e-05	0.000182	CcSEcCtD
Pramipexole—Insomnia—Prednisolone—allergic rhinitis	3.01e-05	0.000182	CcSEcCtD
Pramipexole—Shock—Methylprednisolone—allergic rhinitis	3e-05	0.000181	CcSEcCtD
Pramipexole—Nervous system disorder—Methylprednisolone—allergic rhinitis	2.99e-05	0.000181	CcSEcCtD
Pramipexole—Loss of consciousness—Dexamethasone—allergic rhinitis	2.99e-05	0.00018	CcSEcCtD
Pramipexole—Loss of consciousness—Betamethasone—allergic rhinitis	2.99e-05	0.00018	CcSEcCtD
Pramipexole—Paraesthesia—Prednisolone—allergic rhinitis	2.99e-05	0.00018	CcSEcCtD
Pramipexole—Tachycardia—Triamcinolone—allergic rhinitis	2.99e-05	0.00018	CcSEcCtD
Pramipexole—Tachycardia—Methylprednisolone—allergic rhinitis	2.98e-05	0.00018	CcSEcCtD
Pramipexole—Skin disorder—Methylprednisolone—allergic rhinitis	2.97e-05	0.000179	CcSEcCtD
Pramipexole—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	2.96e-05	0.00155	CbGpPWpGaD
Pramipexole—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	2.96e-05	0.000179	CcSEcCtD
Pramipexole—Hyperhidrosis—Triamcinolone—allergic rhinitis	2.96e-05	0.000178	CcSEcCtD
Pramipexole—Hyperhidrosis—Methylprednisolone—allergic rhinitis	2.95e-05	0.000178	CcSEcCtD
Pramipexole—Convulsion—Betamethasone—allergic rhinitis	2.95e-05	0.000178	CcSEcCtD
Pramipexole—Convulsion—Dexamethasone—allergic rhinitis	2.95e-05	0.000178	CcSEcCtD
Pramipexole—Insomnia—Hydrocortisone—allergic rhinitis	2.94e-05	0.000177	CcSEcCtD
Pramipexole—ADRA2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.94e-05	0.00154	CbGpPWpGaD
Pramipexole—Hypertension—Betamethasone—allergic rhinitis	2.94e-05	0.000177	CcSEcCtD
Pramipexole—Hypertension—Dexamethasone—allergic rhinitis	2.94e-05	0.000177	CcSEcCtD
Pramipexole—Paraesthesia—Hydrocortisone—allergic rhinitis	2.92e-05	0.000176	CcSEcCtD
Pramipexole—Myalgia—Dexamethasone—allergic rhinitis	2.9e-05	0.000175	CcSEcCtD
Pramipexole—Myalgia—Betamethasone—allergic rhinitis	2.9e-05	0.000175	CcSEcCtD
Pramipexole—Anxiety—Betamethasone—allergic rhinitis	2.89e-05	0.000174	CcSEcCtD
Pramipexole—Anxiety—Dexamethasone—allergic rhinitis	2.89e-05	0.000174	CcSEcCtD
Pramipexole—HTR1A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	2.88e-05	0.0015	CbGpPWpGaD
Pramipexole—Discomfort—Betamethasone—allergic rhinitis	2.86e-05	0.000173	CcSEcCtD
Pramipexole—Discomfort—Dexamethasone—allergic rhinitis	2.86e-05	0.000173	CcSEcCtD
Pramipexole—Dyspepsia—Hydrocortisone—allergic rhinitis	2.86e-05	0.000173	CcSEcCtD
Pramipexole—HTR1D—GPCR downstream signaling—TAC1—allergic rhinitis	2.86e-05	0.0015	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.86e-05	0.0015	CbGpPWpGaD
Pramipexole—Hypotension—Methylprednisolone—allergic rhinitis	2.85e-05	0.000172	CcSEcCtD
Pramipexole—DRD5—Signaling Pathways—CYSLTR1—allergic rhinitis	2.85e-05	0.00149	CbGpPWpGaD
Pramipexole—Pain—Prednisolone—allergic rhinitis	2.85e-05	0.000172	CcSEcCtD
Pramipexole—Decreased appetite—Hydrocortisone—allergic rhinitis	2.83e-05	0.00017	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	2.81e-05	0.000169	CcSEcCtD
Pramipexole—Fatigue—Hydrocortisone—allergic rhinitis	2.8e-05	0.000169	CcSEcCtD
Pramipexole—HTR1B—GPCR downstream signaling—TAC1—allergic rhinitis	2.8e-05	0.00146	CbGpPWpGaD
Pramipexole—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	2.79e-05	0.000168	CcSEcCtD
Pramipexole—HTR1D—Signaling Pathways—PTGDR2—allergic rhinitis	2.78e-05	0.00146	CbGpPWpGaD
Pramipexole—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	2.78e-05	0.000168	CcSEcCtD
Pramipexole—Pain—Hydrocortisone—allergic rhinitis	2.78e-05	0.000168	CcSEcCtD
Pramipexole—Oedema—Dexamethasone—allergic rhinitis	2.78e-05	0.000168	CcSEcCtD
Pramipexole—Oedema—Betamethasone—allergic rhinitis	2.78e-05	0.000168	CcSEcCtD
Pramipexole—Insomnia—Triamcinolone—allergic rhinitis	2.77e-05	0.000167	CcSEcCtD
Pramipexole—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	2.76e-05	0.00145	CbGpPWpGaD
Pramipexole—Insomnia—Methylprednisolone—allergic rhinitis	2.76e-05	0.000167	CcSEcCtD
Pramipexole—ADRA2B—Signaling by GPCR—CCL11—allergic rhinitis	2.76e-05	0.00144	CbGpPWpGaD
Pramipexole—Infection—Betamethasone—allergic rhinitis	2.76e-05	0.000166	CcSEcCtD
Pramipexole—Infection—Dexamethasone—allergic rhinitis	2.76e-05	0.000166	CcSEcCtD
Pramipexole—HTR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.76e-05	0.00144	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CCL11—allergic rhinitis	2.75e-05	0.00144	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—TAC1—allergic rhinitis	2.75e-05	0.00144	CbGpPWpGaD
Pramipexole—Paraesthesia—Triamcinolone—allergic rhinitis	2.75e-05	0.000166	CcSEcCtD
Pramipexole—HTR2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.74e-05	0.00144	CbGpPWpGaD
Pramipexole—Feeling abnormal—Prednisolone—allergic rhinitis	2.74e-05	0.000165	CcSEcCtD
Pramipexole—Paraesthesia—Methylprednisolone—allergic rhinitis	2.74e-05	0.000165	CcSEcCtD
Pramipexole—Shock—Betamethasone—allergic rhinitis	2.73e-05	0.000165	CcSEcCtD
Pramipexole—Shock—Dexamethasone—allergic rhinitis	2.73e-05	0.000165	CcSEcCtD
Pramipexole—Dyspnoea—Triamcinolone—allergic rhinitis	2.73e-05	0.000165	CcSEcCtD
Pramipexole—HTR1B—Signaling Pathways—PTGDR2—allergic rhinitis	2.73e-05	0.00143	CbGpPWpGaD
Pramipexole—Nervous system disorder—Betamethasone—allergic rhinitis	2.72e-05	0.000164	CcSEcCtD
Pramipexole—Nervous system disorder—Dexamethasone—allergic rhinitis	2.72e-05	0.000164	CcSEcCtD
Pramipexole—Thrombocytopenia—Dexamethasone—allergic rhinitis	2.72e-05	0.000164	CcSEcCtD
Pramipexole—Thrombocytopenia—Betamethasone—allergic rhinitis	2.72e-05	0.000164	CcSEcCtD
Pramipexole—Tachycardia—Betamethasone—allergic rhinitis	2.71e-05	0.000164	CcSEcCtD
Pramipexole—Tachycardia—Dexamethasone—allergic rhinitis	2.71e-05	0.000164	CcSEcCtD
Pramipexole—Dyspepsia—Triamcinolone—allergic rhinitis	2.69e-05	0.000163	CcSEcCtD
Pramipexole—Dyspepsia—Methylprednisolone—allergic rhinitis	2.69e-05	0.000162	CcSEcCtD
Pramipexole—Hyperhidrosis—Dexamethasone—allergic rhinitis	2.68e-05	0.000162	CcSEcCtD
Pramipexole—Hyperhidrosis—Betamethasone—allergic rhinitis	2.68e-05	0.000162	CcSEcCtD
Pramipexole—DRD4—Signaling Pathways—PTGDR2—allergic rhinitis	2.68e-05	0.0014	CbGpPWpGaD
Pramipexole—Feeling abnormal—Hydrocortisone—allergic rhinitis	2.68e-05	0.000162	CcSEcCtD
Pramipexole—ADRA2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.67e-05	0.0014	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.67e-05	0.0014	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—CCL11—allergic rhinitis	2.66e-05	0.00139	CbGpPWpGaD
Pramipexole—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	2.66e-05	0.00016	CcSEcCtD
Pramipexole—HTR1D—GPCR downstream signaling—IL5—allergic rhinitis	2.66e-05	0.00139	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—CCL11—allergic rhinitis	2.65e-05	0.00139	CbGpPWpGaD
Pramipexole—Anorexia—Dexamethasone—allergic rhinitis	2.65e-05	0.00016	CcSEcCtD
Pramipexole—Anorexia—Betamethasone—allergic rhinitis	2.65e-05	0.00016	CcSEcCtD
Pramipexole—Urticaria—Prednisolone—allergic rhinitis	2.64e-05	0.00016	CcSEcCtD
Pramipexole—Fatigue—Triamcinolone—allergic rhinitis	2.64e-05	0.000159	CcSEcCtD
Pramipexole—Fatigue—Methylprednisolone—allergic rhinitis	2.63e-05	0.000159	CcSEcCtD
Pramipexole—HTR2B—GPCR downstream signaling—TAC1—allergic rhinitis	2.63e-05	0.00138	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.62e-05	0.00137	CbGpPWpGaD
Pramipexole—Pain—Triamcinolone—allergic rhinitis	2.62e-05	0.000158	CcSEcCtD
Pramipexole—HTR1B—GPCR downstream signaling—IL5—allergic rhinitis	2.6e-05	0.00136	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—TAC1—allergic rhinitis	2.59e-05	0.00136	CbGpPWpGaD
Pramipexole—Hypotension—Betamethasone—allergic rhinitis	2.59e-05	0.000157	CcSEcCtD
Pramipexole—Hypotension—Dexamethasone—allergic rhinitis	2.59e-05	0.000157	CcSEcCtD
Pramipexole—Urticaria—Hydrocortisone—allergic rhinitis	2.58e-05	0.000156	CcSEcCtD
Pramipexole—ADRA2C—Signaling by GPCR—CCL11—allergic rhinitis	2.58e-05	0.00135	CbGpPWpGaD
Pramipexole—Abdominal pain—Hydrocortisone—allergic rhinitis	2.57e-05	0.000155	CcSEcCtD
Pramipexole—Body temperature increased—Hydrocortisone—allergic rhinitis	2.57e-05	0.000155	CcSEcCtD
Pramipexole—HTR2B—Signaling Pathways—PTGDR2—allergic rhinitis	2.56e-05	0.00134	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—IL5—allergic rhinitis	2.56e-05	0.00134	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—TAC1—allergic rhinitis	2.54e-05	0.00133	CbGpPWpGaD
Pramipexole—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	2.53e-05	0.000153	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	2.53e-05	0.000153	CcSEcCtD
Pramipexole—Feeling abnormal—Triamcinolone—allergic rhinitis	2.52e-05	0.000152	CcSEcCtD
Pramipexole—Feeling abnormal—Methylprednisolone—allergic rhinitis	2.52e-05	0.000152	CcSEcCtD
Pramipexole—Insomnia—Betamethasone—allergic rhinitis	2.51e-05	0.000152	CcSEcCtD
Pramipexole—Insomnia—Dexamethasone—allergic rhinitis	2.51e-05	0.000152	CcSEcCtD
Pramipexole—DRD4—Signaling by GPCR—TAC1—allergic rhinitis	2.5e-05	0.00131	CbGpPWpGaD
Pramipexole—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	2.5e-05	0.000151	CcSEcCtD
Pramipexole—Paraesthesia—Dexamethasone—allergic rhinitis	2.49e-05	0.00015	CcSEcCtD
Pramipexole—Paraesthesia—Betamethasone—allergic rhinitis	2.49e-05	0.00015	CcSEcCtD
Pramipexole—HTR2A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	2.48e-05	0.0013	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—TAC1—allergic rhinitis	2.48e-05	0.0013	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—IL5—allergic rhinitis	2.46e-05	0.00129	CbGpPWpGaD
Pramipexole—Hypersensitivity—Prednisolone—allergic rhinitis	2.45e-05	0.000148	CcSEcCtD
Pramipexole—DRD3—GPCR downstream signaling—TAC1—allergic rhinitis	2.45e-05	0.00128	CbGpPWpGaD
Pramipexole—Dyspepsia—Dexamethasone—allergic rhinitis	2.44e-05	0.000147	CcSEcCtD
Pramipexole—Dyspepsia—Betamethasone—allergic rhinitis	2.44e-05	0.000147	CcSEcCtD
Pramipexole—HTR2B—GPCR downstream signaling—IL5—allergic rhinitis	2.44e-05	0.00128	CbGpPWpGaD
Pramipexole—Urticaria—Triamcinolone—allergic rhinitis	2.43e-05	0.000147	CcSEcCtD
Pramipexole—Urticaria—Methylprednisolone—allergic rhinitis	2.43e-05	0.000146	CcSEcCtD
Pramipexole—DRD2—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.42e-05	0.00127	CbGpPWpGaD
Pramipexole—Body temperature increased—Triamcinolone—allergic rhinitis	2.42e-05	0.000146	CcSEcCtD
Pramipexole—DRD1—Signaling Pathways—PTGDR2—allergic rhinitis	2.41e-05	0.00126	CbGpPWpGaD
Pramipexole—Abdominal pain—Methylprednisolone—allergic rhinitis	2.41e-05	0.000146	CcSEcCtD
Pramipexole—Decreased appetite—Betamethasone—allergic rhinitis	2.41e-05	0.000146	CcSEcCtD
Pramipexole—Decreased appetite—Dexamethasone—allergic rhinitis	2.41e-05	0.000146	CcSEcCtD
Pramipexole—HTR1D—Signaling by GPCR—IL5—allergic rhinitis	2.41e-05	0.00126	CbGpPWpGaD
Pramipexole—Gastrointestinal disorder—Betamethasone—allergic rhinitis	2.4e-05	0.000145	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	2.4e-05	0.000145	CcSEcCtD
Pramipexole—Hypersensitivity—Hydrocortisone—allergic rhinitis	2.39e-05	0.000144	CcSEcCtD
Pramipexole—Fatigue—Dexamethasone—allergic rhinitis	2.39e-05	0.000144	CcSEcCtD
Pramipexole—Fatigue—Betamethasone—allergic rhinitis	2.39e-05	0.000144	CcSEcCtD
Pramipexole—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.39e-05	0.00125	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—TAC1—allergic rhinitis	2.39e-05	0.00125	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.38e-05	0.00125	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PTGDR2—allergic rhinitis	2.38e-05	0.00125	CbGpPWpGaD
Pramipexole—Pain—Betamethasone—allergic rhinitis	2.37e-05	0.000143	CcSEcCtD
Pramipexole—Pain—Dexamethasone—allergic rhinitis	2.37e-05	0.000143	CcSEcCtD
Pramipexole—HTR1B—Signaling by GPCR—IL5—allergic rhinitis	2.36e-05	0.00124	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—CCL11—allergic rhinitis	2.34e-05	0.00122	CbGpPWpGaD
Pramipexole—Asthenia—Hydrocortisone—allergic rhinitis	2.33e-05	0.000141	CcSEcCtD
Pramipexole—DRD4—Signaling by GPCR—IL5—allergic rhinitis	2.32e-05	0.00122	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—IL5—allergic rhinitis	2.3e-05	0.00121	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—CCL11—allergic rhinitis	2.3e-05	0.0012	CbGpPWpGaD
Pramipexole—Pruritus—Hydrocortisone—allergic rhinitis	2.3e-05	0.000139	CcSEcCtD
Pramipexole—Feeling abnormal—Dexamethasone—allergic rhinitis	2.29e-05	0.000138	CcSEcCtD
Pramipexole—Feeling abnormal—Betamethasone—allergic rhinitis	2.29e-05	0.000138	CcSEcCtD
Pramipexole—DRD3—GPCR downstream signaling—IL5—allergic rhinitis	2.27e-05	0.00119	CbGpPWpGaD
Pramipexole—Gastrointestinal pain—Dexamethasone—allergic rhinitis	2.27e-05	0.000137	CcSEcCtD
Pramipexole—Gastrointestinal pain—Betamethasone—allergic rhinitis	2.27e-05	0.000137	CcSEcCtD
Pramipexole—Hypersensitivity—Triamcinolone—allergic rhinitis	2.25e-05	0.000136	CcSEcCtD
Pramipexole—DRD1—Signaling by GPCR—TAC1—allergic rhinitis	2.25e-05	0.00118	CbGpPWpGaD
Pramipexole—Hypersensitivity—Methylprednisolone—allergic rhinitis	2.25e-05	0.000136	CcSEcCtD
Pramipexole—Diarrhoea—Hydrocortisone—allergic rhinitis	2.22e-05	0.000134	CcSEcCtD
Pramipexole—DRD3—Signaling by GPCR—TAC1—allergic rhinitis	2.22e-05	0.00116	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL5—allergic rhinitis	2.22e-05	0.00116	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—TAC1—allergic rhinitis	2.21e-05	0.00116	CbGpPWpGaD
Pramipexole—Urticaria—Betamethasone—allergic rhinitis	2.21e-05	0.000133	CcSEcCtD
Pramipexole—Urticaria—Dexamethasone—allergic rhinitis	2.21e-05	0.000133	CcSEcCtD
Pramipexole—Dizziness—Prednisolone—allergic rhinitis	2.2e-05	0.000133	CcSEcCtD
Pramipexole—Asthenia—Triamcinolone—allergic rhinitis	2.2e-05	0.000132	CcSEcCtD
Pramipexole—Abdominal pain—Dexamethasone—allergic rhinitis	2.19e-05	0.000132	CcSEcCtD
Pramipexole—Body temperature increased—Dexamethasone—allergic rhinitis	2.19e-05	0.000132	CcSEcCtD
Pramipexole—Body temperature increased—Betamethasone—allergic rhinitis	2.19e-05	0.000132	CcSEcCtD
Pramipexole—Abdominal pain—Betamethasone—allergic rhinitis	2.19e-05	0.000132	CcSEcCtD
Pramipexole—Asthenia—Methylprednisolone—allergic rhinitis	2.19e-05	0.000132	CcSEcCtD
Pramipexole—HTR1D—Signaling Pathways—CYSLTR1—allergic rhinitis	2.18e-05	0.00114	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.17e-05	0.00113	CbGpPWpGaD
Pramipexole—Pruritus—Triamcinolone—allergic rhinitis	2.16e-05	0.000131	CcSEcCtD
Pramipexole—Pruritus—Methylprednisolone—allergic rhinitis	2.16e-05	0.00013	CcSEcCtD
Pramipexole—ADRA2B—Signaling Pathways—PTGDR2—allergic rhinitis	2.15e-05	0.00113	CbGpPWpGaD
Pramipexole—Dizziness—Hydrocortisone—allergic rhinitis	2.15e-05	0.00013	CcSEcCtD
Pramipexole—HTR1B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.14e-05	0.00112	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—TAC1—allergic rhinitis	2.13e-05	0.00112	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—TAC1—allergic rhinitis	2.12e-05	0.00111	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCL11—allergic rhinitis	2.11e-05	0.0011	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CYSLTR1—allergic rhinitis	2.1e-05	0.0011	CbGpPWpGaD
Pramipexole—Rash—Prednisolone—allergic rhinitis	2.1e-05	0.000127	CcSEcCtD
Pramipexole—Dermatitis—Prednisolone—allergic rhinitis	2.1e-05	0.000126	CcSEcCtD
Pramipexole—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	2.09e-05	0.0011	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL5—allergic rhinitis	2.09e-05	0.00109	CbGpPWpGaD
Pramipexole—Diarrhoea—Methylprednisolone—allergic rhinitis	2.09e-05	0.000126	CcSEcCtD
Pramipexole—Headache—Prednisolone—allergic rhinitis	2.08e-05	0.000126	CcSEcCtD
Pramipexole—HTR1A—Signaling Pathways—PTGDR2—allergic rhinitis	2.08e-05	0.00109	CbGpPWpGaD
Pramipexole—Vomiting—Hydrocortisone—allergic rhinitis	2.07e-05	0.000125	CcSEcCtD
Pramipexole—HTR2C—Signaling Pathways—PTGDR2—allergic rhinitis	2.07e-05	0.00108	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCL11—allergic rhinitis	2.07e-05	0.00108	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL5—allergic rhinitis	2.06e-05	0.00108	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—TAC1—allergic rhinitis	2.06e-05	0.00108	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—IL5—allergic rhinitis	2.05e-05	0.00107	CbGpPWpGaD
Pramipexole—Rash—Hydrocortisone—allergic rhinitis	2.05e-05	0.000124	CcSEcCtD
Pramipexole—Dermatitis—Hydrocortisone—allergic rhinitis	2.05e-05	0.000124	CcSEcCtD
Pramipexole—Headache—Hydrocortisone—allergic rhinitis	2.04e-05	0.000123	CcSEcCtD
Pramipexole—DRD4—Signaling Pathways—CCL11—allergic rhinitis	2.03e-05	0.00106	CbGpPWpGaD
Pramipexole—Dizziness—Triamcinolone—allergic rhinitis	2.02e-05	0.000122	CcSEcCtD
Pramipexole—Dizziness—Methylprednisolone—allergic rhinitis	2.02e-05	0.000122	CcSEcCtD
Pramipexole—ADRA2C—Signaling Pathways—PTGDR2—allergic rhinitis	2.01e-05	0.00105	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.01e-05	0.00105	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—TAC1—allergic rhinitis	2e-05	0.00105	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TAC1—allergic rhinitis	2e-05	0.00105	CbGpPWpGaD
Pramipexole—Asthenia—Dexamethasone—allergic rhinitis	1.99e-05	0.00012	CcSEcCtD
Pramipexole—Asthenia—Betamethasone—allergic rhinitis	1.99e-05	0.00012	CcSEcCtD
Pramipexole—HTR1A—GPCR downstream signaling—IL5—allergic rhinitis	1.98e-05	0.00104	CbGpPWpGaD
Pramipexole—Nausea—Prednisolone—allergic rhinitis	1.98e-05	0.000119	CcSEcCtD
Pramipexole—HTR2C—GPCR downstream signaling—IL5—allergic rhinitis	1.97e-05	0.00103	CbGpPWpGaD
Pramipexole—Pruritus—Dexamethasone—allergic rhinitis	1.96e-05	0.000119	CcSEcCtD
Pramipexole—Pruritus—Betamethasone—allergic rhinitis	1.96e-05	0.000119	CcSEcCtD
Pramipexole—Vomiting—Triamcinolone—allergic rhinitis	1.95e-05	0.000117	CcSEcCtD
Pramipexole—Vomiting—Methylprednisolone—allergic rhinitis	1.94e-05	0.000117	CcSEcCtD
Pramipexole—HTR2B—Signaling Pathways—CCL11—allergic rhinitis	1.94e-05	0.00102	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—TAC1—allergic rhinitis	1.94e-05	0.00101	CbGpPWpGaD
Pramipexole—Nausea—Hydrocortisone—allergic rhinitis	1.93e-05	0.000116	CcSEcCtD
Pramipexole—Rash—Triamcinolone—allergic rhinitis	1.93e-05	0.000116	CcSEcCtD
Pramipexole—Dermatitis—Triamcinolone—allergic rhinitis	1.93e-05	0.000116	CcSEcCtD
Pramipexole—HTR2C—Signaling by GPCR—TAC1—allergic rhinitis	1.93e-05	0.00101	CbGpPWpGaD
Pramipexole—Rash—Methylprednisolone—allergic rhinitis	1.93e-05	0.000116	CcSEcCtD
Pramipexole—Dermatitis—Methylprednisolone—allergic rhinitis	1.92e-05	0.000116	CcSEcCtD
Pramipexole—ADRA2C—GPCR downstream signaling—IL5—allergic rhinitis	1.92e-05	0.001	CbGpPWpGaD
Pramipexole—Headache—Triamcinolone—allergic rhinitis	1.92e-05	0.000116	CcSEcCtD
Pramipexole—Headache—Methylprednisolone—allergic rhinitis	1.91e-05	0.000115	CcSEcCtD
Pramipexole—Diarrhoea—Dexamethasone—allergic rhinitis	1.9e-05	0.000115	CcSEcCtD
Pramipexole—Diarrhoea—Betamethasone—allergic rhinitis	1.9e-05	0.000115	CcSEcCtD
Pramipexole—DRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	1.89e-05	0.000992	CbGpPWpGaD
Pramipexole—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.88e-05	0.000983	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—TAC1—allergic rhinitis	1.87e-05	0.00098	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—TAC1—allergic rhinitis	1.87e-05	0.000979	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CYSLTR1—allergic rhinitis	1.87e-05	0.000978	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL5—allergic rhinitis	1.86e-05	0.000975	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL5—allergic rhinitis	1.86e-05	0.000974	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—TAC1—allergic rhinitis	1.84e-05	0.000964	CbGpPWpGaD
Pramipexole—Dizziness—Betamethasone—allergic rhinitis	1.84e-05	0.000111	CcSEcCtD
Pramipexole—Dizziness—Dexamethasone—allergic rhinitis	1.84e-05	0.000111	CcSEcCtD
Pramipexole—DRD1—Signaling Pathways—CCL11—allergic rhinitis	1.83e-05	0.000958	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PTGDR2—allergic rhinitis	1.82e-05	0.000954	CbGpPWpGaD
Pramipexole—Nausea—Triamcinolone—allergic rhinitis	1.82e-05	0.00011	CcSEcCtD
Pramipexole—Nausea—Methylprednisolone—allergic rhinitis	1.81e-05	0.000109	CcSEcCtD
Pramipexole—DRD3—Signaling Pathways—CCL11—allergic rhinitis	1.81e-05	0.000945	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL5—allergic rhinitis	1.8e-05	0.000942	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PTGDR2—allergic rhinitis	1.79e-05	0.000939	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL5—allergic rhinitis	1.79e-05	0.000937	CbGpPWpGaD
Pramipexole—Vomiting—Dexamethasone—allergic rhinitis	1.77e-05	0.000107	CcSEcCtD
Pramipexole—Vomiting—Betamethasone—allergic rhinitis	1.77e-05	0.000107	CcSEcCtD
Pramipexole—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.75e-05	0.000918	CbGpPWpGaD
Pramipexole—Rash—Betamethasone—allergic rhinitis	1.75e-05	0.000106	CcSEcCtD
Pramipexole—Rash—Dexamethasone—allergic rhinitis	1.75e-05	0.000106	CcSEcCtD
Pramipexole—Dermatitis—Betamethasone—allergic rhinitis	1.75e-05	0.000106	CcSEcCtD
Pramipexole—Dermatitis—Dexamethasone—allergic rhinitis	1.75e-05	0.000106	CcSEcCtD
Pramipexole—ADRA2C—Signaling by GPCR—IL5—allergic rhinitis	1.74e-05	0.000911	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—IL5—allergic rhinitis	1.74e-05	0.00091	CbGpPWpGaD
Pramipexole—Headache—Betamethasone—allergic rhinitis	1.74e-05	0.000105	CcSEcCtD
Pramipexole—Headache—Dexamethasone—allergic rhinitis	1.74e-05	0.000105	CcSEcCtD
Pramipexole—HTR2A—GPCR downstream signaling—IL5—allergic rhinitis	1.71e-05	0.000896	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—TAC1—allergic rhinitis	1.7e-05	0.000889	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CYSLTR1—allergic rhinitis	1.69e-05	0.000883	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	1.68e-05	0.000877	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—TAC1—allergic rhinitis	1.67e-05	0.000875	CbGpPWpGaD
Pramipexole—Nausea—Betamethasone—allergic rhinitis	1.65e-05	9.95e-05	CcSEcCtD
Pramipexole—Nausea—Dexamethasone—allergic rhinitis	1.65e-05	9.95e-05	CcSEcCtD
Pramipexole—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	1.63e-05	0.000854	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCL11—allergic rhinitis	1.63e-05	0.000853	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.63e-05	0.000853	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CYSLTR1—allergic rhinitis	1.62e-05	0.000848	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL5—allergic rhinitis	1.58e-05	0.000827	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CYSLTR1—allergic rhinitis	1.58e-05	0.000825	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCL11—allergic rhinitis	1.57e-05	0.000823	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCL11—allergic rhinitis	1.57e-05	0.000819	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	1.56e-05	0.000815	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL5—allergic rhinitis	1.55e-05	0.000813	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TAC1—allergic rhinitis	1.53e-05	0.000802	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCL11—allergic rhinitis	1.52e-05	0.000797	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	1.52e-05	0.000796	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TAC1—allergic rhinitis	1.5e-05	0.000785	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TAC1—allergic rhinitis	1.48e-05	0.000773	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CYSLTR1—allergic rhinitis	1.43e-05	0.000749	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL5—allergic rhinitis	1.42e-05	0.000746	CbGpPWpGaD
Pramipexole—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.42e-05	0.000746	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	1.41e-05	0.00074	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TAC1—allergic rhinitis	1.41e-05	0.000738	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.41e-05	0.000737	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL5—allergic rhinitis	1.4e-05	0.00073	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCL11—allergic rhinitis	1.38e-05	0.000723	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL5—allergic rhinitis	1.37e-05	0.000719	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCL11—allergic rhinitis	1.36e-05	0.000711	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TAC1—allergic rhinitis	1.33e-05	0.000696	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TAC1—allergic rhinitis	1.31e-05	0.000687	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL5—allergic rhinitis	1.31e-05	0.000686	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—SMAD3—allergic rhinitis	1.31e-05	0.000685	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.28e-05	0.00067	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	1.24e-05	0.000647	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL5—allergic rhinitis	1.24e-05	0.000647	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL5—allergic rhinitis	1.22e-05	0.000638	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TAC1—allergic rhinitis	1.18e-05	0.00062	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TAC1—allergic rhinitis	1.14e-05	0.000598	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TAC1—allergic rhinitis	1.14e-05	0.000595	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TAC1—allergic rhinitis	1.11e-05	0.000579	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL5—allergic rhinitis	1.1e-05	0.000576	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL5—allergic rhinitis	1.06e-05	0.000556	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL5—allergic rhinitis	1.06e-05	0.000553	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL5—allergic rhinitis	1.03e-05	0.000538	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TAC1—allergic rhinitis	1e-05	0.000525	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—SMAD3—allergic rhinitis	1e-05	0.000525	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TAC1—allergic rhinitis	9.88e-06	0.000517	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—SMAD3—allergic rhinitis	9.82e-06	0.000514	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TGFB1—allergic rhinitis	9.68e-06	0.000507	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—SMAD3—allergic rhinitis	9.66e-06	0.000506	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL5—allergic rhinitis	9.33e-06	0.000488	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—SMAD3—allergic rhinitis	9.22e-06	0.000483	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL5—allergic rhinitis	9.18e-06	0.000481	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TGFB1—allergic rhinitis	9.04e-06	0.000473	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	8.99e-06	0.00047	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SMAD3—allergic rhinitis	8.7e-06	0.000455	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SMAD3—allergic rhinitis	8.58e-06	0.000449	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	8.35e-06	0.000437	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SMAD3—allergic rhinitis	7.75e-06	0.000406	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SMAD3—allergic rhinitis	7.48e-06	0.000391	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SMAD3—allergic rhinitis	7.44e-06	0.000389	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	7.34e-06	0.000384	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SMAD3—allergic rhinitis	7.24e-06	0.000379	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—NFKB1—allergic rhinitis	6.66e-06	0.000348	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SMAD3—allergic rhinitis	6.57e-06	0.000344	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SMAD3—allergic rhinitis	6.46e-06	0.000338	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	5.88e-06	0.000308	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TGFB1—allergic rhinitis	5.54e-06	0.00029	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—NFKB1—allergic rhinitis	5.1e-06	0.000267	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—NFKB1—allergic rhinitis	4.99e-06	0.000261	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—NFKB1—allergic rhinitis	4.91e-06	0.000257	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—NFKB1—allergic rhinitis	4.69e-06	0.000245	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—NFKB1—allergic rhinitis	4.42e-06	0.000231	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—NFKB1—allergic rhinitis	4.36e-06	0.000228	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TGFB1—allergic rhinitis	4.25e-06	0.000222	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TGFB1—allergic rhinitis	4.16e-06	0.000218	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TGFB1—allergic rhinitis	4.09e-06	0.000214	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—NFKB1—allergic rhinitis	3.94e-06	0.000206	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TGFB1—allergic rhinitis	3.91e-06	0.000204	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—NFKB1—allergic rhinitis	3.8e-06	0.000199	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—NFKB1—allergic rhinitis	3.78e-06	0.000198	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TGFB1—allergic rhinitis	3.68e-06	0.000193	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—NFKB1—allergic rhinitis	3.68e-06	0.000193	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TGFB1—allergic rhinitis	3.63e-06	0.00019	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NFKB1—allergic rhinitis	3.34e-06	0.000175	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NFKB1—allergic rhinitis	3.28e-06	0.000172	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TGFB1—allergic rhinitis	3.28e-06	0.000172	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TGFB1—allergic rhinitis	3.17e-06	0.000166	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TGFB1—allergic rhinitis	3.15e-06	0.000165	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TGFB1—allergic rhinitis	3.07e-06	0.00016	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	2.99e-06	0.000156	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TGFB1—allergic rhinitis	2.78e-06	0.000146	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TGFB1—allergic rhinitis	2.74e-06	0.000143	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	2.49e-06	0.00013	CbGpPWpGaD
